Breaking News Instant updates and real-time market news.

2021-02-25 13:11:23 W Wayfair $261.58 / +3.58 (+1.39%) 13:11 02/25/21 02/25 13:11 02/25/21 13:11	Wayfair price target raised to $260 from $250 at Wells Fargo Wells Fargo analyst Zachary Fadem raised the firm's price target on Wayfair to $260 from $250, attributing today's rally in the stock to re-accelerating trends in late Q4 and early Q1, the company's better than expected profitability and an uptick in long-term margin expectations. While Fadem said Wayfair's margin expansion "remains impressive despite slowing growth," and he says the business looks increasingly well-positioned to maintain share gains and profitability in a post-pandemic world, the analyst keeps an Equal Weight rating on the shares as he struggles to see near-term upside given that the company will be facing what he calls "the toughest y/y lap in our coverage."	25 Feb
W Wayfair $261.58 / +3.58 (+1.39%) 02/25/21 Morgan Stanley Wayfair upgraded to Equal Weight at Morgan Stanley on improved long-term outlook 02/25/21 Morgan Stanley Wayfair upgraded to Equal Weight from Underweight at Morgan Stanley 02/25/21 DA Davidson Overstock.com price target raised to $121 from $103 at DA Davidson 02/18/21 Cowen Wayfair price target raised to $375 from $360 at Cowen

2021-02-25 13:11:23

Wayfair

$261.58 / +3.58 (+1.39%)

13:11

02/25/21

02/25

13:11

02/25/21

13:11

Wayfair price target raised to $260 from $250 at Wells Fargo

Wells Fargo analyst Zachary Fadem raised the firm's price target on Wayfair to $260 from $250, attributing today's rally in the stock to re-accelerating trends in late Q4 and early Q1, the company's better than expected profitability and an uptick in long-term margin expectations. While Fadem said Wayfair's margin expansion "remains impressive despite slowing growth," and he says the business looks increasingly well-positioned to maintain share gains and profitability in a post-pandemic world, the analyst keeps an Equal Weight rating on the shares as he struggles to see near-term upside given that the company will be facing what he calls "the toughest y/y lap in our coverage."

25
Feb

W Wayfair

$261.58 / +3.58 (+1.39%)

02/25/21 Morgan Stanley: Wayfair upgraded to Equal Weight at Morgan Stanley on improved long-term outlook

02/25/21 Morgan Stanley: Wayfair upgraded to Equal Weight from Underweight at Morgan Stanley

02/25/21 DA Davidson: Overstock.com price target raised to $121 from $103 at DA Davidson

02/18/21 Cowen: Wayfair price target raised to $375 from $360 at Cowen

TODAY'S FREE FLY STORIES

Downgrade	Southern Copper downgraded to Sell from Neutral at UBS » 16:19 04/20/21 04/20 16:19 04/20/21 16:19 SCCO Southern Copper $71.32 / -3.23 (-4.33%) UBS analyst Andreas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SCCO Southern Copper $71.32 / -3.23 (-4.33%) 12/07/20 Southern Copper chairman sells 176,195 common shares 11/25/20 Southern Copper chairman sells 210.7K shares of common stock 11/23/20 Southern Copper chairman sells 118.7K shares of common stock 11/04/20 Southern Copper chairman sells 88,677 common shares SCCO Southern Copper $71.32 / -3.23 (-4.33%) 02/17/21 Citi Southern Copper upgraded to Neutral from Sell at Citi 01/06/21 Barclays Southern Copper initiated with an Underweight at Barclays 12/09/20 UBS Southern Copper cut to Neutral at UBS after 39% year-to-date rally 12/09/20 UBS Southern Copper downgraded to Neutral from Buy at UBS SCCO Southern Copper $71.32 / -3.23 (-4.33%) 01/25/21 Southern Copper reports Q4 EPS 76c, consensus 70c
Hot Stocks	Edwards Lifesciences CEO says 'continued confidence' in 2021 outlook » 16:19 04/20/21 04/20 16:19 04/20/21 16:19 EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) "We recognize that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/31/21 Edwards Lifesciences announces new data from COMMENCE clinical trial 01/27/21 Edwards Lifesciences falls over 3% to $82 per share after Q4 earnings miss 01/27/21 Edwards Lifesciences sees COVID impact on sales in 'start of the year' 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 04/15/21 Atlantic Equities Atlantic Equities starts Edwards Lifesciences at Neutral 04/05/21 Evercore ISI Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle' 04/05/21 Evercore ISI Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 16:18 Today Edwards Lifesciences sees Q2 adjusted EPS 54c-60c, consensus 52c 16:17 Today Edwards Lifesciences raises FY21 adjusted EPS to $2.07-$2.27 from $2.00-$2.20 16:15 Today Edwards Lifesciences reports Q1 EPS 54c, consensus 47c 13:22 Today Notable companies reporting after market close EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/27/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 17:30 Today Edwards Lifesciences - EW 05/04/21 Edwards Lifesciences Corp. EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 11/17/20 Early notable gainers among liquid option names on November 17th
Hot Stocks	CSX slips about 2% below $97 per share after Q1 results 16:19 04/20/21 04/20 16:19 04/20/21 16:19 CSX CSX $98.51 / -0.18 (-0.18%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CSX CSX $98.51 / -0.18 (-0.18%) 16:17 Today CSX continues to target CAPEX in $1.7B-$1.8B range 16:16 Today CSX reports Q1 operating ratio 60.9% vs. 58.7% last year 04/14/21 North American rail traffic rose 22.2% in week ended April 10, AAR says 04/07/21 North American rail traffic rose 17.6% in week ended April 3 CSX CSX $98.51 / -0.18 (-0.18%) 03/26/21 Vertical Research CSX reinstated with a Hold at Vertical Research 03/25/21 Citi Norfolk Southern shares have another $100 of potential upside, says Citi 01/25/21 Argus CSX price target raised to $98 from $90 at Argus 01/22/21 Fly Intel: Top five analyst downgrades CSX CSX $98.51 / -0.18 (-0.18%) 16:05 Today CSX reports Q1 EPS 93c, consensus 95c 13:22 Today Notable companies reporting after market close 01/21/21 CSX reports Q4 EPS 99c, consensus $1.00 01/21/21 Notable companies reporting after market close CSX CSX $98.51 / -0.18 (-0.18%) 01/21/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 16:30 Today CSX - CSX 05/07/21 CSX Corp. CSX CSX $98.51 / -0.18 (-0.18%) 15:19 Today CSX options imply 5.4% move in share price post-earnings 03/22/21 Early notable gainers among liquid option names on March 22nd 02/16/21 Unusually active option classes on open February 16th 01/21/21 CSX options imply 4.6% move in share price post-earnings
Conference/Events	UBS technology analyst to hold an analyst/industry conference call » 16:18 04/20/21 04/20 16:18 04/20/21 16:18 Technology Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Earnings	Edwards Lifesciences sees Q2 adjusted EPS 54c-60c, consensus 52c » 16:18 04/20/21 04/20 16:18 04/20/21 16:18 EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) Sees Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/31/21 Edwards Lifesciences announces new data from COMMENCE clinical trial 01/27/21 Edwards Lifesciences falls over 3% to $82 per share after Q4 earnings miss 01/27/21 Edwards Lifesciences sees COVID impact on sales in 'start of the year' 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 04/15/21 Atlantic Equities Atlantic Equities starts Edwards Lifesciences at Neutral 04/05/21 Evercore ISI Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle' 04/05/21 Evercore ISI Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 16:17 Today Edwards Lifesciences raises FY21 adjusted EPS to $2.07-$2.27 from $2.00-$2.20 16:15 Today Edwards Lifesciences reports Q1 EPS 54c, consensus 47c 13:22 Today Notable companies reporting after market close 01/27/21 Edwards Lifesciences sees Q1 adjusted EPS 43c-50c, consensus 50c EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/27/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 17:30 Today Edwards Lifesciences - EW 05/04/21 Edwards Lifesciences Corp. EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 11/17/20 Early notable gainers among liquid option names on November 17th

Hot Stocks	Regional Management expands operations to Illinois » 16:17 04/20/21 04/20 16:17 04/20/21 16:17 RM Regional Management $37.47 / -0.25 (-0.66%) Regional Management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RM Regional Management $37.47 / -0.25 (-0.66%) 10/30/20 Regional Management rises 13.1% RM Regional Management $37.47 / -0.25 (-0.66%) 11/12/20 Janney Montgomery Scott Regional Management downgraded to Neutral from Buy at Janney Montgomery Scott 05/14/20 BMO Capital BMO Capital upgrades Regional Management to Outperform, sees potential to double 05/14/20 BMO Capital Regional Management upgraded to Outperform from Market Perform at BMO Capital 05/07/20 JMP Securities Regional Management price target lowered to $20 from $35 at JMP Securities RM Regional Management $37.47 / -0.25 (-0.66%) 02/10/21 Regional Management reports Q4 EPS $1.28, consensus 85c 10/29/20 Regional Management reports Q3 EPS $1.01, consensus 55c 05/04/21 Regional Management - RM 05/20/21 Regional Management Corp
Hot Stocks	CSX continues to target CAPEX in $1.7B-$1.8B range » 16:17 04/20/21 04/20 16:17 04/20/21 16:17 CSX CSX $98.51 / -0.18 (-0.18%) The company also… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CSX CSX $98.51 / -0.18 (-0.18%) 16:16 Today CSX reports Q1 operating ratio 60.9% vs. 58.7% last year 04/14/21 North American rail traffic rose 22.2% in week ended April 10, AAR says 04/07/21 North American rail traffic rose 17.6% in week ended April 3 03/31/21 North American rail traffic rose 14.1% in week ended March 27, AAR reports CSX CSX $98.51 / -0.18 (-0.18%) 03/26/21 Vertical Research CSX reinstated with a Hold at Vertical Research 03/25/21 Citi Norfolk Southern shares have another $100 of potential upside, says Citi 01/25/21 Argus CSX price target raised to $98 from $90 at Argus 01/22/21 Fly Intel: Top five analyst downgrades CSX CSX $98.51 / -0.18 (-0.18%) 16:05 Today CSX reports Q1 EPS 93c, consensus 95c 13:22 Today Notable companies reporting after market close 01/21/21 CSX reports Q4 EPS 99c, consensus $1.00 01/21/21 Notable companies reporting after market close CSX CSX $98.51 / -0.18 (-0.18%) 01/21/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 16:30 Today CSX - CSX 05/07/21 CSX Corp. CSX CSX $98.51 / -0.18 (-0.18%) 15:19 Today CSX options imply 5.4% move in share price post-earnings 03/22/21 Early notable gainers among liquid option names on March 22nd 02/16/21 Unusually active option classes on open February 16th 01/21/21 CSX options imply 4.6% move in share price post-earnings
Hot Stocks	Premier Financial raises quarterly dividend to 26c per share from 24c » 16:17 04/20/21 04/20 16:17 04/20/21 16:17 PFC Premier Financial $31.52 / -1.525 (-4.61%) The Board of Directors… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PFC Premier Financial $31.52 / -1.525 (-4.61%) 01/26/21 Premier Financial increases share buyback authorization to up to 2M shares 01/26/21 Premier Financial raises quarterly dividend 9.1% to 25c per share 01/26/21 Premier Financial's Gary Small to become CEO on April 1, 2021 PFC Premier Financial $31.52 / -1.525 (-4.61%) 01/27/21 Keefe Bruyette Keefe Bruyette says time to buy Premier Financial, ups target to $34 12/28/20 Piper Sandler Premier Financial price target lowered to $25.50 from $26.50 at Piper Sandler PFC Premier Financial $31.52 / -1.525 (-4.61%) 16:16 Today Premier Financial reports Q1 EPS $1.10, consensus 76c 01/26/21 Premier Financial reports Q4 EPS ex-items 87c, consensus 69c 10/20/20 Premier Financial reports Q3 ex-items EPS 69c, consensus 59c 05/18/21 Virtual Ohio Community Bank Field Trip 04/21/21 Premier Financial - PFC 04/29/21 Premier Financial Corp
Earnings	Edwards Lifesciences raises FY21 adjusted EPS to $2.07-$2.27 from $2.00-$2.20 » 16:17 04/20/21 04/20 16:17 04/20/21 16:17 EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) FY21 consensus $2.13.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/31/21 Edwards Lifesciences announces new data from COMMENCE clinical trial 01/27/21 Edwards Lifesciences falls over 3% to $82 per share after Q4 earnings miss 01/27/21 Edwards Lifesciences sees COVID impact on sales in 'start of the year' 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 04/15/21 Atlantic Equities Atlantic Equities starts Edwards Lifesciences at Neutral 04/05/21 Evercore ISI Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle' 04/05/21 Evercore ISI Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 16:15 Today Edwards Lifesciences reports Q1 EPS 54c, consensus 47c 13:22 Today Notable companies reporting after market close 01/27/21 Edwards Lifesciences sees Q1 adjusted EPS 43c-50c, consensus 50c 01/27/21 Edwards Lifesciences backs FY21 adjusted EPS view $2.00-$2.20, consensus $2.15 EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/27/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 17:30 Today Edwards Lifesciences - EW 05/04/21 Edwards Lifesciences Corp. EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 11/17/20 Early notable gainers among liquid option names on November 17th
Technical Analysis	NASDAQ market internals summary » 16:17 04/20/21 04/20 16:17 04/20/21 16:17 $NSD NASDAQ Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary

Earnings	Premier Financial reports Q1 EPS $1.10, consensus 76c » 16:16 04/20/21 04/20 16:16 04/20/21 16:16 PFC Premier Financial $31.52 / -1.525 (-4.61%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PFC Premier Financial $31.52 / -1.525 (-4.61%) 01/26/21 Premier Financial increases share buyback authorization to up to 2M shares 01/26/21 Premier Financial raises quarterly dividend 9.1% to 25c per share 01/26/21 Premier Financial's Gary Small to become CEO on April 1, 2021 PFC Premier Financial $31.52 / -1.525 (-4.61%) 01/27/21 Keefe Bruyette Keefe Bruyette says time to buy Premier Financial, ups target to $34 12/28/20 Piper Sandler Premier Financial price target lowered to $25.50 from $26.50 at Piper Sandler PFC Premier Financial $31.52 / -1.525 (-4.61%) 01/26/21 Premier Financial reports Q4 EPS ex-items 87c, consensus 69c 10/20/20 Premier Financial reports Q3 ex-items EPS 69c, consensus 59c 05/18/21 Virtual Ohio Community Bank Field Trip 04/21/21 Premier Financial - PFC 04/29/21 Premier Financial Corp
Hot Stocks	CSX reports Q1 operating ratio 60.9% vs. 58.7% last year » 16:16 04/20/21 04/20 16:16 04/20/21 16:16 CSX CSX $98.51 / -0.18 (-0.18%) Reports Q1 train velocity… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CSX CSX $98.51 / -0.18 (-0.18%) 04/14/21 North American rail traffic rose 22.2% in week ended April 10, AAR says 04/07/21 North American rail traffic rose 17.6% in week ended April 3 03/31/21 North American rail traffic rose 14.1% in week ended March 27, AAR reports 03/24/21 North American rail traffic rose 9.5% in week ended March 20, AAR reports CSX CSX $98.51 / -0.18 (-0.18%) 03/26/21 Vertical Research CSX reinstated with a Hold at Vertical Research 03/25/21 Citi Norfolk Southern shares have another $100 of potential upside, says Citi 01/25/21 Argus CSX price target raised to $98 from $90 at Argus 01/22/21 Fly Intel: Top five analyst downgrades CSX CSX $98.51 / -0.18 (-0.18%) 16:05 Today CSX reports Q1 EPS 93c, consensus 95c 13:22 Today Notable companies reporting after market close 01/21/21 CSX reports Q4 EPS 99c, consensus $1.00 01/21/21 Notable companies reporting after market close CSX CSX $98.51 / -0.18 (-0.18%) 01/21/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 16:30 Today CSX - CSX 05/07/21 CSX Corp. CSX CSX $98.51 / -0.18 (-0.18%) 15:19 Today CSX options imply 5.4% move in share price post-earnings 03/22/21 Early notable gainers among liquid option names on March 22nd 02/16/21 Unusually active option classes on open February 16th 01/21/21 CSX options imply 4.6% move in share price post-earnings
Technical Analysis	NYSE market internals summary » 16:16 04/20/21 04/20 16:16 04/20/21 16:16 $NYE NYSE Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary
Earnings	Edwards Lifesciences reports Q1 EPS 54c, consensus 47c » 16:15 04/20/21 04/20 16:15 04/20/21 16:15 EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) Reports Q1 revenue $1.2B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/31/21 Edwards Lifesciences announces new data from COMMENCE clinical trial 01/27/21 Edwards Lifesciences falls over 3% to $82 per share after Q4 earnings miss 01/27/21 Edwards Lifesciences sees COVID impact on sales in 'start of the year' 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 04/15/21 Atlantic Equities Atlantic Equities starts Edwards Lifesciences at Neutral 04/05/21 Evercore ISI Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle' 04/05/21 Evercore ISI Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 13:22 Today Notable companies reporting after market close 01/27/21 Edwards Lifesciences sees Q1 adjusted EPS 43c-50c, consensus 50c 01/27/21 Edwards Lifesciences backs FY21 adjusted EPS view $2.00-$2.20, consensus $2.15 01/27/21 Edwards Lifesciences reports Q4 adjusted EPS 50c, consensus 53c EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 01/27/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers 17:30 Today Edwards Lifesciences - EW 05/04/21 Edwards Lifesciences Corp. EW Edwards Lifesciences $89.62 / +1.16 (+1.31%) 11/17/20 Early notable gainers among liquid option names on November 17th
Conference/Events	UBS electric equip/multi-industry analysts hold analyst/industry conference call » 16:14 04/20/21 04/20 16:14 04/20/21 16:14 Electrical Equipment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Hot Stocks	LabCorp launches COVID-19 test kits for small business » 16:14 04/20/21 04/20 16:14 04/20/21 16:14 LH LabCorp $259.87 / -0.3 (-0.12%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LH LabCorp $259.87 / -0.3 (-0.12%) 03/26/21 LabCorp appoints Kathryn Wengel to Board of Directors 02/24/21 Walgreens says Pixel by Labcorp COVID-19 PCR test to be available OTC nationwide 02/23/21 Adaptive Biotechnologies expands collaboration with LabCorp 02/18/21 Pacific Biosciences announces LabCorp's addition of PacBio Sequel II Systems LH LabCorp $259.87 / -0.3 (-0.12%) 04/14/21 Truist LabCorp price target raised to $300 from $280 at Truist 02/12/21 JPMorgan LabCorp price target raised to $279 from $261 at JPMorgan 02/12/21 Mizuho LabCorp price target raised to $267 from $242 at Mizuho 02/12/21 Citi LabCorp price target raised to $278 from $257 at Citi LH LabCorp $259.87 / -0.3 (-0.12%) 02/11/21 LabCorp sees FY21 adjusted EPS $19.00-$23.00, consensus $20.14 02/11/21 LabCorp reports Q4 adjusted EPS $10.56, consensus $8.11 10/27/20 LabCorp continues to not provide 2020 guidance 10/27/20 LabCorp reports Q3 adjusted EPS $8.41, consensus $5.25 LH LabCorp $259.87 / -0.3 (-0.12%) 02/23/21 Jana Partners nominates directors to LabCorp board, Reuters reports 02/23/21 LabCorp higher after Bloomberg says Jana nominated directors 02/23/21 Jana Partners nominated directors to LabCorp board, Bloomberg reports 01/12/21 LabCorp CEO: COVID vaccine recipients don't need antibody test after, CNBC says LH LabCorp $259.87 / -0.3 (-0.12%) 03/16/21 Higher COVID vaccine reimbursement seen as 'windfall' for drug retailers 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 04/29/21 LabCorp - LH 05/12/21 Laboratory Corporation of America Hldgs LH LabCorp $259.87 / -0.3 (-0.12%) 03/24/21 Early notable gainers among liquid option names on March 24th 02/17/21 Early notable gainers among liquid option names on February 17th 10/27/20 Early notable gainers among liquid option names on October 27th
Initiation	Conagra Brands initiated with a Neutral at Citi » 16:14 04/20/21 04/20 16:14 04/20/21 16:14 CAG Conagra Brands $38.27 / +0.415 (+1.10%) Citi analyst Wendy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CAG Conagra Brands $38.27 / +0.415 (+1.10%) 04/08/21 Conagra Brands says 'sustained increase in demand in retail segments' QTD 04/08/21 Conagra Brands CEO says Q3 results 'benefited' from recent investments 04/06/21 Conagra Brands names Chaly Jo Moyen as CSO 02/23/21 Conagra Brands CEO: We expect the at-home eating trend to continue CAG Conagra Brands $38.27 / +0.415 (+1.10%) 04/09/21 RBC Capital Conagra Brands price target raised to $38 from $37 at RBC Capital 01/12/21 Jefferies Conagra Brands price target lowered to $40 from $41 at Jefferies 01/08/21 Credit Suisse Conagra Brands price target lowered to $33 from $34 at Credit Suisse 01/05/21 Credit Suisse Conagra Brands downgraded to Underperform from Neutral at Credit Suisse CAG Conagra Brands $38.27 / +0.415 (+1.10%) 04/08/21 Conagra Brands backs FY22 adjusted EPS view $2.63-$2.73, consensus $2.60 04/08/21 Conagra Brands sees Q4 adjusted EPS 49c-55c, consensus 51c 04/08/21 Conagra Brands reports Q3 adjusted EPS 59c, consensus 58c 04/07/21 Notable companies reporting before tomorrow's open CAG Conagra Brands $38.27 / +0.415 (+1.10%) 03/10/21 Conagra Brands in talks to sell Hebrew National brand to JBS, WSJ reports 02/16/21 Kraft Heinz, Conagra Brands could raise cost of certain goods, Reuters reports CAG Conagra Brands $38.27 / +0.415 (+1.10%) 04/08/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Pre-market Movers
Downgrade	Piper downgrades j2 Global to Neutral with spinoff catalyst seen played out » 16:14 04/20/21 04/20 16:14 04/20/21 16:14 JCOM j2 Global / + As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events JCOM j2 Global / + 04/19/21 j2 Global trading resumes 04/19/21 j2 Global to separate into two publicly traded companies 04/19/21 j2 Global trading halted, news dissemination 03/30/21 Campaigner launches "Campaigner SMS" JCOM j2 Global / + 16:10 Today Piper Sandler j2 Global downgraded to Neutral from Overweight at Piper Sandler 02/18/21 Citi j2 Global price target raised to $140 from $100 at Citi 02/16/21 Susquehanna j2 Global price target raised to $250 from $120 at Susquehanna 02/16/21 DA Davidson j2 Global price target raised to $130 from $115 at DA Davidson JCOM j2 Global / + 02/11/21 j2 Global sees FY21 adjusted EPS $8.93-$9.27, consensus $8.71 02/11/21 j2 Global reports Q4 adjusted EPS $3.11, consensus $2.79 11/02/20 j2 Global raises FY20 adjusted EPS view to $7.85-$8.00 from $7.17-$7.41 11/02/20 j2 Global reports Q3 adjusted EPS $2.02, consensus $1.77 JCOM j2 Global / + 02/11/21 Fly Intel: After-Hours Movers 11/02/20 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 05/11/21 j2 Global - JCOM 05/07/21 J2 Global Inc.
Hot Stocks	Avalara acquires DAVO Technologies operational assets, terms not disclosed » 16:13 04/20/21 04/20 16:13 04/20/21 16:13 AVLR Avalara $139.38 / -4.295 (-2.99%) Avalara announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events AVLR Avalara $139.38 / -4.295 (-2.99%) 12/29/20 Avalara to acquire INPOSIA, terms not disclosed 12/06/20 Preclinical data demonstrate anti-viral activity of AlloVir's ALVR109 12/02/20 Avalara acquires London-based insurance tax solution provider Impendulo 11/20/20 Avalara CEO sells 55K shares of common stock AVLR Avalara $139.38 / -4.295 (-2.99%) 04/07/21 Morgan Stanley Morgan Stanley downgrades Vertex to Underweight on strengthening competition 04/07/21 Morgan Stanley Avalara initiated with an Overweight at Morgan Stanley 02/11/21 Needham Avalara price target raised to $210 from $190 at Needham 02/11/21 Canaccord Avalara price target raised to $205 from $195 at Canaccord AVLR Avalara $139.38 / -4.295 (-2.99%) 02/10/21 Avalara sees FY21 revenue $628M-$633M, consensus $620.77M 02/10/21 Avalara sees Q1 revenue $142M-$144N, consensus $140.59M 02/10/21 Avalara reports Q4 EPS 9c, consensus (6c) 02/10/21 Notable companies reporting after market close 06 Aug 05/24/21 Global Technology, Media & Communications Virtual Conference
Downgrade	Freeport McMoRan downgraded to Neutral from Buy at UBS » 16:13 04/20/21 04/20 16:13 04/20/21 16:13 FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) UBS analyst Andreas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) 03/05/21 Freeport McMoRan's Ford sells 300,000 common shares 02/02/21 Freeport McMoRan reinstate common stock dividend, adopts new payout policy 02/02/21 Freeport McMoRan names Richard C. Adkerson chairman of the board 01/26/21 Freeport McMoRan: Copper sales on track to grow 20% in 2021 vs. 2020 FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) 04/06/21 Raymond James Freeport McMoRan upgraded to Outperform from Market Perform at Raymond James 04/05/21 Raymond James Freeport McMoRan upgraded to Outperform from Market Perform at Raymond James 03/24/21 Fly Intel: Top five analyst downgrades 03/24/21 Morgan Stanley Morgan Stanley 'taking profits,' downgrades Freeport McMoRan to Equal Weight FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) 01/26/21 Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) 02/19/21 Barrick CEO tells Bloomberg window closed on possible Freeport deal FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) 11/11/20 Fly Intel: After-Hours Movers 05/05/21 Copper Day Virtual Conference 04/22/21 Freeport McMoRan - FCX FCX Freeport McMoRan $35.86 / -1.47 (-3.94%) 04/14/21 Freeport McMoRan call volume above normal and directionally bullish 04/14/21 Early notable gainers among liquid option names on April 14th 03/26/21 Early notable gainers among liquid option names on March 26th 03/11/21 Freeport McMoRan call volume above normal and directionally bullish

Earnings	Tenet sees Q2 adjusted EPS 69c-$1.39, consensus 81c » 16:13 04/20/21 04/20 16:13 04/20/21 16:13 THC Tenet $52.12 / -0.42 (-0.80%) Sees Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events THC Tenet $52.12 / -0.42 (-0.80%) 04/19/21 Tenet general counsel Andrews to retire 03/09/21 Tenet's Conifer Health announces multiyear contract extention with NorthShore 02/10/21 Tenet shareholder Glenview Capital issues letter supporting Conifer spin-off 01/11/21 Tenet Healthcare sees Q4 adjusted EBITDA to meet or exceed $773M THC Tenet $52.12 / -0.42 (-0.80%) 04/09/21 Mizuho Tenet price target raised to $55 from $48 at Mizuho 02/11/21 Credit Suisse Tenet price target raised to $58 from $52 at Credit Suisse 02/11/21 Citi Tenet price target raised to $58 from $50 at Citi 01/21/21 UBS Tenet price target raised to $60 from $37 at UBS THC Tenet $52.12 / -0.42 (-0.80%) 16:12 Today Tenet raises FY21 adjusted EPS view to $4.12-$5.46 from $3.52-$4.81 16:11 Today Tenet reports Q1 adjusted EPS $1.30, consensus 72c 02/09/21 Tenet sees FY21 adjusted EPS $3.52-$4.81, consensus $3.11 02/09/21 Tenet sees Q1 adjusted EPS 23c-93c, consensus 54c THC Tenet $52.12 / -0.42 (-0.80%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says 10/28/20 Workers at Tenet hospitals in California threaten strike, SGVT says THC Tenet $52.12 / -0.42 (-0.80%) 02/09/21 Fly Intel: After-Hours Movers 11/14/20 Week in review: How Trump's policies moved stocks 10/20/20 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/21/21 Tenet - THC 05/06/21 Tenet Healthcare
Hot Stocks	Lumos Pharma names Lori Lawley as CFO » 16:12 04/20/21 04/20 16:12 04/20/21 16:12 LUMO Lumos Pharma $12.00 / +0.26 (+2.21%) Lumos Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LUMO Lumos Pharma $12.00 / +0.26 (+2.21%) 03/21/21 Lumos Pharma says data shows greater GH response in PGHD from LUM-201 03/04/21 Lumos Pharma announces results of data analyses from PGHD studies 11/10/20 Lumos initiated Phase 2b OraGrowtH210 Trial evaluating oral LUM-201 in PGHD LUMO Lumos Pharma $12.00 / +0.26 (+2.21%) 04/13/21 JonesTrading Lumos Pharma initiated with a Buy at JonesTrading 03/11/21 Stifel Lumos Pharma upgraded to Buy from Hold at Stifel 12/03/20 Fly Intel: Top five analyst initiations 12/03/20 Cantor Fitzgerald Lumos Pharma initiated with an Overweight at Cantor Fitzgerald LUMO Lumos Pharma $12.00 / +0.26 (+2.21%) 11/10/20 Lumos Pharma reports Q3 EPS 21c, consensus (64c) 04/27/21 KOL Webinar on LUM-201 04/27/21 Lumos Pharma - LUMO 05/19/21 Lumos Pharma Inc
Earnings	Tenet raises FY21 adjusted EPS view to $4.12-$5.46 from $3.52-$4.81 » 16:12 04/20/21 04/20 16:12 04/20/21 16:12 THC Tenet $52.15 / -0.39 (-0.74%) Consensus $4.18. Raises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events THC Tenet $52.15 / -0.39 (-0.74%) 04/19/21 Tenet general counsel Andrews to retire 03/09/21 Tenet's Conifer Health announces multiyear contract extention with NorthShore 02/10/21 Tenet shareholder Glenview Capital issues letter supporting Conifer spin-off 01/11/21 Tenet Healthcare sees Q4 adjusted EBITDA to meet or exceed $773M THC Tenet $52.15 / -0.39 (-0.74%) 04/09/21 Mizuho Tenet price target raised to $55 from $48 at Mizuho 02/11/21 Credit Suisse Tenet price target raised to $58 from $52 at Credit Suisse 02/11/21 Citi Tenet price target raised to $58 from $50 at Citi 01/21/21 UBS Tenet price target raised to $60 from $37 at UBS THC Tenet $52.15 / -0.39 (-0.74%) 16:11 Today Tenet reports Q1 adjusted EPS $1.30, consensus 72c 02/09/21 Tenet sees FY21 adjusted EPS $3.52-$4.81, consensus $3.11 02/09/21 Tenet sees Q1 adjusted EPS 23c-93c, consensus 54c 02/09/21 Tenet reports Q4 adjusted EPS $4.72, consensus $1.70 THC Tenet $52.15 / -0.39 (-0.74%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says 10/28/20 Workers at Tenet hospitals in California threaten strike, SGVT says THC Tenet $52.15 / -0.39 (-0.74%) 02/09/21 Fly Intel: After-Hours Movers 11/14/20 Week in review: How Trump's policies moved stocks 10/20/20 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/21/21 Tenet - THC 05/06/21 Tenet Healthcare
Earnings	W. R. Berkley reports Q1 EPS $1.08, consensus 81c » 16:11 04/20/21 04/20 16:11 04/20/21 16:11 WRB W. R. Berkley $80.89 / +0.24 (+0.30%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events WRB W. R. Berkley $80.89 / +0.24 (+0.30%) 03/18/21 Hartford Financial jumps after report of Chubb takeover approach 12/31/20 W. R. Berkley announces sale of real estate investment 12/28/20 W. R. Berkley launches special purpose insurer Lifson Re 10/20/20 W. R. Berkley reports Q3 gross premiums written $2.26B vs. $2.09B last year WRB W. R. Berkley $80.89 / +0.24 (+0.30%) 04/07/21 Wells Fargo W. R. Berkley initiated with an Overweight at Wells Fargo 02/24/21 UBS W. R. Berkley upgraded to Buy from Neutral at UBS 02/24/21 UBS W. R. Berkley upgraded to Buy from Neutral at UBS 01/11/21 Credit Suisse W. R. Berkley price target raised to $73 from $68 at Credit Suisse WRB W. R. Berkley $80.89 / +0.24 (+0.30%) 01/26/21 W. R. Berkley reports Q4 EPS $1.67, consensus 79c 17:00 Today W. R. Berkley - WRB
Earnings	Tenet reports Q1 adjusted EPS $1.30, consensus 72c » 16:11 04/20/21 04/20 16:11 04/20/21 16:11 THC Tenet $52.19 / -0.35 (-0.67%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events THC Tenet $52.19 / -0.35 (-0.67%) 04/19/21 Tenet general counsel Andrews to retire 03/09/21 Tenet's Conifer Health announces multiyear contract extention with NorthShore 02/10/21 Tenet shareholder Glenview Capital issues letter supporting Conifer spin-off 01/11/21 Tenet Healthcare sees Q4 adjusted EBITDA to meet or exceed $773M THC Tenet $52.19 / -0.35 (-0.67%) 04/09/21 Mizuho Tenet price target raised to $55 from $48 at Mizuho 02/11/21 Credit Suisse Tenet price target raised to $58 from $52 at Credit Suisse 02/11/21 Citi Tenet price target raised to $58 from $50 at Citi 01/21/21 UBS Tenet price target raised to $60 from $37 at UBS THC Tenet $52.19 / -0.35 (-0.67%) 02/09/21 Tenet sees FY21 adjusted EPS $3.52-$4.81, consensus $3.11 02/09/21 Tenet sees Q1 adjusted EPS 23c-93c, consensus 54c 02/09/21 Tenet reports Q4 adjusted EPS $4.72, consensus $1.70 02/09/21 Notable companies reporting after market close THC Tenet $52.19 / -0.35 (-0.67%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says 10/28/20 Workers at Tenet hospitals in California threaten strike, SGVT says THC Tenet $52.19 / -0.35 (-0.67%) 02/09/21 Fly Intel: After-Hours Movers 11/14/20 Week in review: How Trump's policies moved stocks 10/20/20 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/21/21 Tenet - THC 05/06/21 Tenet Healthcare

Events

Earnings calls, analyst events, roadshows and more

IBKR
Today at 16:30

Interactive Brokers - IBKR Conference Calls
IWSY
Today at 16:30

ImageWare - IWSY Conference Calls
CSX
Today at 16:30

CSX - CSX Conference Calls
ISRG
Today at 16:30

Intuitive Surgical - ISRG Conference Calls
BHTG
Today at 16:30

BioHiTech Global - BHTG Conference Calls
LRN
Today at 17:00

Stride - LRN Conference Calls
FOR
Today at 17:00

Forestar Group - FOR Conference Calls
WRB
Today at 17:00

W. R. Berkley - WRB Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
UMPQ
Today at 17:00

Umpqua Holdings Corp. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One $24.00-27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink $15.00-17.00 5.31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham $43.00-50.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler $12.00-14.00 5.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong $177.92 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim $164.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR $16.00-18.00 11.819M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA $28.00-31.00 13.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB $18.00-20.00 26.316M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush $14.00-16.00 5.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim $16.00-18.00 7.353M Shares SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist $19.00-21.00 20M Shares TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel $15.00-17.00 9.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Wayfair price target raised to $260 from $250 at Wells Fargo

TODAY'S FREE FLY STORIES

Get Full Fly Access